Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion
NEW YORK (AP) - Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.
More from Virginia Business
Virginia Lawyers Weekly
Securities claims can't be based on puffery, boasting
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-247 -- Zeigler v. Eastman Chemical Company
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
Court clarifies 'statutory employees' exception
Virginia Business
•
Dec 5, 2022
Virginia Lawyers Weekly
022-2-243 -- Capps v. Newmark Southern Region LLC
Virginia Business
•
Dec 5, 2022